Showing results (71-80 of 162) with videos related to
Sort By:
Pageof 17
Klinische Wochenschrift|December 2, 1985
Functional surface structures on human natural killer cellsR E Schmidt, T Hercend, S F Schlossman, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1998
CD3/TCR complex-associated lymphocyte activation gene-3 molecules inhibit CD3/TCR signalingS Hannier, M Tournier, G Bismuth, et al.European Journal of Immunology|October 10, 2001
LAP, a lymphocyte activation gene-3 (LAG-3)-associated protein that binds to a repeated EP motif in the intracellular region of LAG-3, may participate in the down-regulation of the CD3/TCR activation pathwayN Iouzalen, S Andreae, S Hannier, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1991
Further evidence for a gamma/delta T cell receptor-mediated TCT.1/CD48 recognitionF Mami-Chouaib, P Del Porto, D Delorme, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1983
Characterization of an antigen expressed by human natural killer cellsJ D Griffin, T Hercend, R Beveridge, et al.European Journal of Immunology|July 1, 1988
Triggering of the phosphoinositide transduction pathway by a monoclonal antibody specific for the human gamma/delta T cell receptorG Bismuth, F Faure, I Theodorou, et al.Journal of the National Cancer Institute|June 1, 1981
Prevention of spontaneous tumors of aged mice by immunopharmacologic manipulation: study of immune antitumor mechanismsM Bruley-Rosset, T Hercend, J Martinez, et al.European Journal of Cancer (Oxford, England : 1990)|May 4, 2001
A combination of interleukin-2 and 60 nm cationic supramolecular biovectors for the treatment of established tumours by subcutaneous or intranasal administrationS El mir, A Casanova, D Betbeder, et al.European Journal of Immunology|March 1, 1989
Regulation of human B cell activation and antibody production by non-major histocompatibility complex-restricted cytotoxic T lymphocytesF Boué, C Goujard, J F Delfraissy, et al.European Journal of Immunology|December 22, 1999
Lymphocyte activation gene-3 induces tumor regression and antitumor immune responsesP Prigent, S El Mir, M Dréano, et al.Pageof 17